- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Staging IV NSCLC in China
Total 653 results
-
Guangzhou Institute of Respiratory DiseaseNot yet recruitingStaging IV NSCLCChina
-
Fudan UniversityUnknown
-
Shanghai Chest HospitalBristol-Myers SquibbCompletedNSCLC Stage IV | Checkpoint InhibitorChina
-
Fujian Cancer HospitalUnknownChemotherapy Effect | NSCLC Stage IVChina
-
Xiaorong DongUnknownHealthy Subjects | NSCLC Stage IV | NSCLC, Stage III | NSCLC, Stage I | NSCLC, Stage IIChina
-
Peking Union Medical CollegeRecruitingNSCLC Stage IV | EGFR Activating Mutation | NSCLC Stage IIIB | NSCLC, RecurrentChina
-
Shanghai Pharmaceuticals Holding Co., LtdWithdrawn
-
Shanghai Chest HospitalRecruitingNSCLC | NSCLC Stage IV | NSCLC, RecurrentChina
-
Fudan UniversityNot yet recruitingNSCLC Stage IV | NSCLC, RecurrentChina
-
Shanghai Chest HospitalThe Affiliated Hospital of Qingdao University; Zhejiang University; Anhui Provincial...RecruitingNSCLC Stage IV | NSCLC Stage IIIB | NSCLC Stage IIICChina
-
Daping Hospital and the Research Institute of Surgery...CompletedNSCLC | Advanced Cancer | EGFR Gene Amplification | Stage IV NSCLC | Stage IIIB NSCLCChina
-
Shandong Provincial HospitalUnknown
-
Kiang Wu HospitalCompleted
-
Fudan UniversityRecruitingNSCLC Stage IVChina
-
Fujian Cancer HospitalNot yet recruiting
-
Sichuan UniversityInnovent Biologics (Suzhou) Co. Ltd.Completed
-
Zhejiang Cancer HospitalRecruiting
-
The First People's Hospital of LianyungangHengrui Yuanzheng Bio-Technology Co., Ltd.Unknown
-
Shanghai Henlius BiotechRecruiting
-
Tang-Du HospitalRecruitingNSCLC Stage IV | OligometastasisChina
-
The Affiliated Hospital of Qingdao UniversityUnknownNSCLC Stage IV | PD-1 | ARID1AChina
-
Fudan UniversityCompletedNSCLC Stage IV | EGFR Activating MutationChina
-
Baodong QinUnknownNSCLC Stage IV | Anlotinib | EGFR T790M-negative | JS001China
-
Peking University Cancer Hospital & InstituteBetta Pharmaceuticals Co., Ltd.RecruitingNSCLC Stage IV | NSCLC Stage IIIB | ALK PositiveChina
-
Jacobio Pharmaceuticals Co., Ltd.RecruitingNSCLC | AML | SCLC | Ovarian Carcinoma | Malignant Tumor | ESCC | CRPC | MFChina
-
Eucure (Beijing) Biopharma Co., LtdWithdrawnHCC | NSCLC Stage IV | NSCLC Stage IIIBChina, Australia, Taiwan, Armenia, Austria
-
Beta Pharma, Inc.Completed
-
Shanghai Henlius BiotechCompleted
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdCompleted
-
Fudan UniversityRecruiting
-
Jiangsu Province Nanjing Brain HospitalRecruiting
-
TYK Medicines, IncRecruiting
-
Wuhan YZY Biopharma Co., Ltd.Not yet recruitingA Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLCNSCLC Stage IV | Malignant Pleural EffusionsChina
-
Fudan UniversityNot yet recruiting
-
Betta Pharmaceuticals Co., Ltd.Unknown
-
Shanghai Chest HospitalUnknownNSCLC | SBRT | GM-CSFChina
-
Xuanzhu Biopharmaceutical Co., Ltd.Not yet recruiting
-
Jacobio Pharmaceuticals Co., Ltd.RecruitingNSCLC | Solid Tumor | CRCChina
-
Beta Pharma, Inc.Completed
-
Jiangsu Aosaikang Pharmaceutical Co., Ltd.CompletedLocally Advanced or Metastatic NSCLCChina
-
Jiangsu Aosaikang Pharmaceutical Co., Ltd.CompletedLocally Advanced or Metastatic NSCLCChina
-
Xiaohua ZhuRecruitingNSCLC Stage IV | PD-L1 Gene AmplificationChina
-
Simcere Pharmaceutical Co., LtdUnknownAdvanced NSCLC | Recurrent NSCLCChina
-
Zhejiang Cancer HospitalRecruitingBrain Metastases | NSCLC Stage IV | ImmunotherapyChina
-
Henan Cancer HospitalRecruitingMagnetic Resonance Imaging | Prognosis | Esophageal Cancer TNM StagingChina
-
Shanghai Gebaide Biotechnology Co., Ltd.UnknownNon-small-cell Lung Cancer (NSCLC) Stage IVChina
-
Guangzhou Institute of Respiratory DiseaseShanghai Junshi Bioscience Co., Ltd.UnknownIIIb/IV NSCLC With T790M Positive Mutations Failed to Osimertinib TherapyChina
-
Xiaorong DongUnknownBrain Metastases | NSCLC Stage IV | Sintilimab | SRSChina
-
Shanghai Chest HospitalMerck Sharp & Dohme LLCRecruiting
-
Guangdong Provincial People's HospitalRecruitingNSCLC, Stage I | Disease Free Survival | Pulmonary Function AssessmentChina